Your browser doesn't support javascript.
loading
Corrigendum to "The use of cannabinoids as anticancer agents" [Prog. Neuro-Psychopharmacol. Biol. Psychiatry 64 (2016) 259-266].
Velasco, Guillermo; Hernández-Tiedra, Sonia; Dávila, David; Lorente, Mar.
Afiliación
  • Velasco G; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University of Madrid, Spain; Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Spain. Electronic address: gvelasco@quim.ucm.es.
  • Hernández-Tiedra S; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University of Madrid, Spain.
  • Dávila D; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University of Madrid, Spain.
  • Lorente M; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University of Madrid, Spain.
Prog Neuropsychopharmacol Biol Psychiatry ; 74: 57, 2017 03 06.
Article en En | MEDLINE | ID: mdl-28063470
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Año: 2017 Tipo del documento: Article